Rabeprazole sodium enteric tablets and enteric capsules are both preparations of rabeprazole sodium, their therapeutic purposes are the same, and there is no difference in drug action. Rabeprazole sodium enteric-coated tablets and enteric-coated capsules are both preparations of rabeprazole sodium, the main difference is that the two coating materials are different, but they are all for the same purpose, the purpose is to break down and function in the small intestine. Enteric-coated tablets and enteric-coated capsules are made differently and treat essentially the same diseases, both treat gastric ulcers, duodenal ulcers, anastomotic ulcers, reflux esophagitis, and Dreiemann’s syndrome. Adverse effects of the drug include itching, rash, palpitations, myalgia, chest pain, dry mouth, dyspepsia, etc. The drug is contraindicated in patients who are allergic to rabeprazole sodium, benzimidazole substitutes, or to any of the excipients used in the preparation of this agent. It is contraindicated in pregnant and lactating women. The specific choice of which dosage form should be in accordance with the doctor’s instructions, do not choose yourself randomly, and do not change the drug without authorization in the middle of the process.